[go: up one dir, main page]

WO2007020222A3 - Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof - Google Patents

Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof Download PDF

Info

Publication number
WO2007020222A3
WO2007020222A3 PCT/EP2006/065199 EP2006065199W WO2007020222A3 WO 2007020222 A3 WO2007020222 A3 WO 2007020222A3 EP 2006065199 W EP2006065199 W EP 2006065199W WO 2007020222 A3 WO2007020222 A3 WO 2007020222A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
composition containing
protein fraction
active substance
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/065199
Other languages
French (fr)
Other versions
WO2007020222A2 (en
Inventor
Piermario Biava
Mariano Bizzarri
Alberto Astaldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STEEL Srl
Original Assignee
STEEL Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STEEL Srl filed Critical STEEL Srl
Publication of WO2007020222A2 publication Critical patent/WO2007020222A2/en
Publication of WO2007020222A3 publication Critical patent/WO2007020222A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical composition containing a protein fraction, obtained from oviparous embryos at precise stages of differentiation, which is much more active than the crude extract in blocking tumor growth and pathologies controlled by the p53 anti-oncogene. Said fraction, in addition to its greater antitumor advantage, also presents the advantage of better characterization and greater ease of administration in human therapy.
PCT/EP2006/065199 2005-08-12 2006-08-10 Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof Ceased WO2007020222A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2005A001572 2005-08-12
IT001572A ITMI20051572A1 (en) 2005-08-12 2005-08-12 PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE SUBSTANCE A PROTEIN FRACTION EXTRACTED FROM EMBRYOS OF OVIPARIANS IN THE PERIOD OF CELLULAR DIFFERENTIATION AND RELATIVE PREPARATION PROCESS

Publications (2)

Publication Number Publication Date
WO2007020222A2 WO2007020222A2 (en) 2007-02-22
WO2007020222A3 true WO2007020222A3 (en) 2007-04-12

Family

ID=37492494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/065199 Ceased WO2007020222A2 (en) 2005-08-12 2006-08-10 Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof

Country Status (2)

Country Link
IT (1) ITMI20051572A1 (en)
WO (1) WO2007020222A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337537B8 (en) * 2008-03-19 2011-08-01 Joan Cunill Aixela PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES.
IT1400147B1 (en) * 2010-03-16 2013-05-17 Univ Roma USE OF A MORPHOGENIC FIELD FOR THE REVERSION OF THE PHENOTYPE OF TUMOR CELLS
US9750773B2 (en) * 2014-08-07 2017-09-05 Michele BIAVA Factors extracted from fish embryos and use of mixtures thereof in the control of stem cell multiplication and differentiation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888172A (en) * 1982-09-23 1989-12-19 Alfaceu Corporation Pharmaceutical for treating tumors and methods for making it
WO1998011905A1 (en) * 1996-09-20 1998-03-26 Adriana Carluccio Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process
US6037446A (en) * 1990-11-28 2000-03-14 Envision Gestational agents for controlling cell proliferation
EP1374703A1 (en) * 2002-06-20 2004-01-02 Pier Mario Biava Use of a non-human animal embryo extract for the preparation of a nutritive substance and a dietetic-nutraceutical supplement
WO2004043401A2 (en) * 2002-11-13 2004-05-27 Wackvom Limited Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888172A (en) * 1982-09-23 1989-12-19 Alfaceu Corporation Pharmaceutical for treating tumors and methods for making it
US6037446A (en) * 1990-11-28 2000-03-14 Envision Gestational agents for controlling cell proliferation
WO1998011905A1 (en) * 1996-09-20 1998-03-26 Adriana Carluccio Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process
EP1374703A1 (en) * 2002-06-20 2004-01-02 Pier Mario Biava Use of a non-human animal embryo extract for the preparation of a nutritive substance and a dietetic-nutraceutical supplement
WO2004043401A2 (en) * 2002-11-13 2004-05-27 Wackvom Limited Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Also Published As

Publication number Publication date
WO2007020222A2 (en) 2007-02-22
ITMI20051572A1 (en) 2007-02-13

Similar Documents

Publication Publication Date Title
KR102105532B1 (en) Method for derivation of inducible Pluripotent stem cells and inducible Pluripotent stem cells produced using the same
WO2006044860A3 (en) Thiadiazole compounds and methods of use
KR101487935B1 (en) A pharmaceutical composition comprising extract or fraction of Salvia plebeia R. Br. for preventing or treating STAT3-mediated disease
WO2018005519A3 (en) Cancer treatment combinations
US20240415920A1 (en) Peptide having activity of preventing hair loss or promoting hair growth, and use thereof
KR101888779B1 (en) Use of isoquinoline alkaloid derivative for preparing drug capable of promoting ampk activity
WO2009079220A3 (en) Recombinant elastase proteins and methods of manufacturing and use thereof
CN104606260A (en) Pharmaceutical composition for assisting chemotherapy drugs and application thereof
KR20160064966A (en) Medical composition and applications thereof used for secondary chemotherapy drugs
JP6389958B2 (en) Medicinal use of anti-tumor for rutile pentacyclic triterpene saponins
JP5854674B2 (en) Dipeptidyl peptidase IV inhibitor
WO2009151714A3 (en) Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions
CN103045531A (en) Application of ginsenoside Rd for inducing mesenchymal stem cell to be directionally differentiated in to hepatic cell in vitro
WO2007020222A3 (en) Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof
JP5999957B2 (en) APJ activator
EP3277260A1 (en) Erodium crassifolium l'her plant extracts and uses thereof
WO2006010084A3 (en) A system for delivering therapeutic agents into living cells and cell nuclei
Gao et al. Angelica dahurica extract and its effective component bergapten alleviated hepatic fibrosis by activating FXR signaling pathway
CN103408528A (en) Chroman compound, as well as preparation method and application thereof
KR101547996B1 (en) Skin topical composition for treating wound, recovering wound or preventing forming scar
CN103826651A (en) Medicinal composition containing wild papaya extract
KR20180059318A (en) Cosmetic composition comprising an extract of a mixture comprising baked glycyrrhiza uralensis fisch, cyperus rotundus l. and curcuma longa l.
ES2909387T3 (en) Plant extracts enriched with ipolamiide derivatives as immunosuppressants to treat immune disorders
NL2039994B1 (en) An application of iturin family lipopeptides in the preparation of drugs for the prevention and/or treatment of non-alcoholic fatty liver disease (nafld)
CN103450321B (en) A kind of drop triterpenoid compound and its preparation method and application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC EPO FORM 1205A DATED 19-06-2008

122 Ep: pct application non-entry in european phase

Ref document number: 06792772

Country of ref document: EP

Kind code of ref document: A2